- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02757092
The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery (VATSMIPMEP)
The Efficacy of Home-Based Pulmonary Rehabilitation Training in Aged Patients With Lung Tumor After Video-assisted Thoracic Surgery:A Clinical Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pulmonary-related surgeries remain some potential risks according to the previous evidence-based studies. Particularly, individuals who were over 65 years of age with smoking, chronic pulmonary disease, wheezy, cardiovascular comorbidities, upper respiratory infection were at the high risk of pulmonary complications after surgery,which accounted for approximately 2% to 40% of occurrence rate. The average mortality rate due to surgery was approximately 2%-8% in patients aged more than 65 years.Pulmonary rehabilitation could effectively reduce pulmonary complications and dyspnea as well as improve lung function, quality of life, exercise ability, and functional status of patients after traditional heart and thoracic surgery.But efficacy of home-based pulmonary rehabilitation for older adults following thoracoscopic surgery, it has not received much attention.
This study employed a prospective, randomized, and controlled clinical design to determine the efficacy of home-based pulmonary rehabilitation in older adults after VATS. All participants underwent preoperative and initial postoperative pulmonary rehabilitation during their hospital stay and were randomly assigned to the experimental or control group at the time of discharge. The control group received standard health education, whereas the experimental group received home-based pulmonary rehabilitation in addition to standard health education. Objective and personal subjective outcome measurements were performed before hospital discharge and 2, 6, and 12 weeks after discharge The control group received standard care. Considering the principle for exercise progression, we divided the home-based rehabilitation program into two stages (0-2 weeks and 3-6 weeks).The exercise program was adjusted in the second week when patients visited the outpatient department of the hospital for follow-up. The home-based rehabilitation program included (1) breathing exercises (pursed-lip and diaphragmatic breathing) and coughing exercises, (2) aerobic exercises (upper and lower limb exercises and walking), (3) incentive spirometry training (Triflo-II), and (4) threshold load training of the inspiratory muscle. In the first stage (0-2 weeks), the aerobic exercise intensity was targeted to reach 10-11 points on the 20-point Borg rating of perceived exercise (RPE) scale. Patients raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min; in addition, they walked at a comfortable speed for 15 min twice per day. Incentive spirometry training (Triflo-II) was performed 8-10 times per hour. We used a threshold load trainer for inspiratory muscle training (30 breaths each time, twice per day) with the initial pressure set at 25%-30% of the maximum inspiratory pressure.
In the second stage (3-6 weeks), the aerobic exercise intensity was targeted to reach 12-15 points on the RPE scale. Patients performed upper-limb resistance exercise (raising of a 250-cc water bottle) and lower-limb stepping for 20 min per day as well as walking exercise (slow walking for 5 min and fast walking for 2 min, followed by 5-min slow walking, for a total of 30 min). Incentive spirometry training (Triflo-II) was performed 8-10 times per hour, and a threshold load trainer was used to train the inspiratory muscle (30 breaths each time, twice per day), with the pressure intensity adjusted to more than 5% of that in the first stage.Researchers contacted patients at home every week through phone calls to monitor the occurrence of any uncomfortable reaction and to encourage patients to continue their rehabilitation program.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kaohsiung, Taiwan, 83342
- Chang Gung Memorial Hospital
-
-
Niaosong
-
Kaohsiung, Niaosong, Taiwan, 83342
- Chang Gung Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed consent
- The men and women over the age of 65
- admission to undergo VATS.
- consciousness and ability to communicate
- ability to undergo 6 weeks of a home-based pulmonary rehabilitation program
Exclusion Criteria:
- refusal to participate
- unplanned emergency surgery
- hemodynamic instability
- received other surgery within a month postsurgery
- unconsciousness after surgery
- bedridden and upper or lower limb weakness
- received radiation and chemotherapy postsurgery
- implementation of thoracoscopic surgery for biopsy only
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Home-based rehabilitation program
0-2 weeks,1.
aerobic exercise intensity was targeted to reach 10-11 points of perceived exercise (RPE) scale 2. raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min 3.walked at a comfortable speed for 15 min twice per day.4.
Triflo-II was performed 8-10 times per hour.
inspiratory muscle training with the initial pressure set at 25%-30% of the maximum inspiratory pressure.3-6
weeks, aerobic exercise reach 12-15 points on the RPE scale.
upper-limb resistance exercise (raising of a 250-cc water bottle) and lower-limb stepping for 20 min per day , walking exercise for a total of 30 min.
Triflo-II was performed 8-10 times per hour, and train the inspiratory muscle with the pressure intensity adjusted to more than 5% of that in the first stage.
|
(1) breathing exercises (pursed-lip and diaphragmatic breathing) and coughing exercises, (2) aerobic exercises (upper and lower limb exercises and walking), (3) incentive spirometry training (Triflo-II), and (4) threshold load training of the inspiratory muscle.
In the first stage (0-2 weeks), the aerobic exercise intensity was targeted to reach 10-11 points on the 20-point Borg rating of perceived exercise (RPE) scale.
Patients raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min; in addition, they walked at a comfortable speed for 15 min twice per day.
Incentive spirometry training (Triflo-II) was performed 8-10 times per hour.
We used a threshold load trainer for inspiratory muscle training (30 breaths each time, twice per day) with the initial pressure set at 25%-30% of the maximum inspiratory pressure.
|
Active Comparator: standard care
control group accept the pulmonary rehabilitation (breathing exercise, extremities exercise, breathing muscle training, incentive spirometry (Triflo-II) training, intermittent positive pressure ventilation, chest physical therapy and pain control) only in operation stage on before op-day 3 day and after op-day and without home based pulmonary rehabilitation.
|
(1) breathing exercises (pursed-lip and diaphragmatic breathing) and coughing exercises, (2) aerobic exercises (upper and lower limb exercises and walking), (3) incentive spirometry training (Triflo-II), and (4) threshold load training of the inspiratory muscle.
In the first stage (0-2 weeks), the aerobic exercise intensity was targeted to reach 10-11 points on the 20-point Borg rating of perceived exercise (RPE) scale.
Patients raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min; in addition, they walked at a comfortable speed for 15 min twice per day.
Incentive spirometry training (Triflo-II) was performed 8-10 times per hour.
We used a threshold load trainer for inspiratory muscle training (30 breaths each time, twice per day) with the initial pressure set at 25%-30% of the maximum inspiratory pressure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Discharge 2weeks Exercise Capacity
Time Frame: assessed at discharge 2weeks
|
Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise .
The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M)higher scores mean a better outcome.
|
assessed at discharge 2weeks
|
Discharge 6 Weeks Exercise Capacity
Time Frame: assessed at discharge.6weeks
|
Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise .
The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M)higher scores mean a better outcome.
|
assessed at discharge.6weeks
|
Discharge 12 Weeks Exercise Capacity
Time Frame: assessed at discharge 12 weeks
|
Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise .
The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M).higher scores mean a better outcome.
|
assessed at discharge 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Discharge 2 Weeks Forced Vital Capacity (FVC in Liter(L)/Sec)
Time Frame: assessments at 2 weeks after discharge
|
Forced vital capacity (FVC in L/sec) assessment by pulmonary function test.Normal values in healthy males aged 20-60 from 4.5-3.5 L/sec,and for females from 3.25-2.5
L/sec ,and whether higher scores mean a better outcome.
|
assessments at 2 weeks after discharge
|
Discharge 2weeks Forced Expiratory Volume in 1 Second(FEV1,Liter(L)/Sec)
Time Frame: assessed at 2 weeks after discharge
|
The Forced Expiratory Volume in 1 Second parameter measures the volume of air that was exhaled into the mouthpiece in the first second after a full inhalation.
The Measured column represents the total volume exhaled during the first second, in liters.
Normal values in healthy males aged 20-60 range from 4.5 to 3.5 liters, and normal values for females aged 20-60 range from 3.25 to 2.5 liters.
The Predicted column compares the actual volume breathed out during the first second of your test to an average of the normal volume breathed out in 1 second for a person of the same gender, height, and age.
This value is expressed as a percentage, with normal test values being between 80% and 120% of the average (predicted) values.and
whether higher scores mean a better outcome.
|
assessed at 2 weeks after discharge
|
Discharge 2weeks MMEF 25-75%(Liter(L)/Sec)
Time Frame: assessed at discharge 2weeks
|
Forced expiratory flow (FEF) is the flow (or speed) of air coming out of the lung during the middle portion of a forced expiration.
It can be given at discrete times, generally defined by what fraction of the forced vital capacity (FVC) has been exhaled.
The usual discrete intervals are 25%, 50% and 75%, usually 25-75% (FEF25-75%).Predicted normal values for FEF depend on age, sex, height, mass and ethnicity as well as the research study that they are based on assessment by pulmonary function test and higher scores mean a better outcome.
|
assessed at discharge 2weeks
|
Discharge 2weeks Peak Expiratory Flow Rate(PEFR , Liter(L)/Sec)
Time Frame: assessed at discharge 2weeks
|
Peak expiratory flow rate (PEFR in liter(L)/sec) assessment by pulmonary function test.It measures the airflow through the bronchi and thus the degree of obstruction in the airways.
Peak expiratory flow is typically measured in units of liters per second (L/sec).when
measured as part of spirometry.The normal range 500-700 L/sec In men, for women, the normal range is 380-500 L/sec.higher
scores mean a better outcome.
|
assessed at discharge 2weeks
|
Discharge 2weeks Inspiratory Muscle Strength(MIP,cmH2O)
Time Frame: assessed at discharge 2 weeks.
|
Inspiratory muscle strength as assessed by Maximum inspiratory pressure (MIP, cmH2O).The MIP is a measure of inspiratory muscle strength produced by a sub-atmospheric pressure The normal.range of MIP in elderly people approximately 60 cm H2O for men and 40 cm H2O for women .An absolute MIP value of < - 40 cm H2O is always abnormal,and higher scores was mean a better outcome.
|
assessed at discharge 2 weeks.
|
Discharge 2weeks Expiratory Muscle Strength(MEP,cmH2O)
Time Frame: assessed at discharge 2 weeks
|
The Maximal Expiratory Pressure (MEP) are global measures of the maximal strength of the respiratory muscles.(MEP,
cmH2O) .MEP is a supra-atmospheric pressure which can be developed in an effort of the abdominal and intercostal muscles.Expiratory muscle strength assesses extrathoracic muscle health.An absolute MEP value of < 80 cmH2O is always abnormal, and higher scores mean a better outcome.
|
assessed at discharge 2 weeks
|
Discharge 2 Weeks Modified Borg Score
Time Frame: assessed at discharge 2 weeks
|
Dyspnea score as assessed by Modified Borg score, The literature review clearly showed that the Modified Borg score was a valid and reliable tool when used in pulmonary medicine and in exercise physiology studies.The scale used was perceived exertion adapted to be appropriate for measuring dyspnea.
This consisted of a vertical scale labelled 0-10, with corresponding verbal expressions of progressively increasing perceived sensation intensity.
It starts at number 0 that mean breathing is no difficulty at all and progresses through to number 10 that mean breathing difficulty is maximal.so
higher scores mean a worse outcome
|
assessed at discharge 2 weeks
|
Discharge 2weeks Lung Expansion Capacity
Time Frame: assessed at discharge 2 weeks
|
Lung expansion capacity as assessed by incentive spirometry with the flow-oriented device( Triflow II,volume × seconds) (ml).Incentive spirometry that feedback respiratory training can improve respiratory function, endurance for exercise capacity,Wide flow rate range from 600 - 1200(volume × seconds) (ml).higher
scores mean a better outcome.
|
assessed at discharge 2 weeks
|
Postoperative 2 Weeks Pulmonary Complications
Time Frame: at 2weeks after discharge
|
Pulmonary complication as assessed by Chest X-ray.pneumonia.lung
collapse.atelectasis.emphysema
and pleural effusion were collected.some
patients have two pulmonary complications at the same time, such as emphysem and infiltration, so the total number is not necessarily equal to 18.
|
at 2weeks after discharge
|
Discharge 6 Weeks Forced Vital Capacity(Liter(L)/Sec)
Time Frame: assessments at discharge 6 weeks
|
Forced vital capacity (FVC in (liter(L)/sec)) assessment by pulmonary function test.Normal values in healthy males aged 20-60 from 4.5-3.5 (liter(L)/sec),and for females from 3.25-2.5
(liter(L)/sec) ,and whether higher scores mean a better outcome.
|
assessments at discharge 6 weeks
|
Discharge 6 Weeks Forced Expiratory Volume in 1 Second (FEV1,Liter(L)/Sec)
Time Frame: assessed at discharge 6weeks
|
The Forced Expiratory Volume in 1 Second parameter measures the volume of air that was exhaled into the mouthpiece in the first second after a full inhalation.
The Measured column represents the total volume exhaled during the first second, in liters.
Normal values in healthy males aged 20-60 range from 4.5 to 3.5 liters, and normal values for females aged 20-60 range from 3.25 to 2.5 liters.
The Predicted column compares the actual volume breathed out during the first second of your test to an average of the normal volume breathed out in 1 second for a person of the same gender, height, and age.
This value is expressed as a percentage, with normal test values being between 80% and 120% of the average (predicted) values.and
whether higher scores mean a better outcome.
|
assessed at discharge 6weeks
|
Discharge 6weeks MMEF 25-75%(Liter(L)/Sec)
Time Frame: assessed at discharge 6 weeks
|
Forced expiratory flow (FEF) is the flow (or speed) of air coming out of the lung during the middle portion of a forced expiration.
It can be given at discrete times, generally defined by what fraction of the forced vital capacity (FVC) has been exhaled.
The usual discrete intervals are 25%, 50% and 75%, usually 25-75% (FEF25-75%).Predicted normal values for FEF depend on age, sex, height, mass and ethnicity as well as the research study that they are based on assessment by pulmonary function test and higher scores mean a better outcome.
|
assessed at discharge 6 weeks
|
Discharge 6weeks Peak Expiratory Flow Rate(PEFR in Liter( L)/Sec)
Time Frame: assessed at discharge .6weeks
|
Peak expiratory flow rate (PEFR in liter(L)/sec) assessment by pulmonary function test.It measures the airflow through the bronchi and thus the degree of obstruction in the airways.
Peak expiratory flow is typically measured in units of liters per second (L/sec).when
measured as part of spirometry.The normal range 500-700 L/sec In men, for women, the normal range is 380-500 L/sec.higher
scores mean a better outcome.
|
assessed at discharge .6weeks
|
Discharge 6 Weeks Inspiratory Muscle Strength(MIP,cmH2O)
Time Frame: assessed at discharge6 weeks.
|
Inspiratory muscle strength as assessed by Maximum inspiratory pressure (MIP, cmH2O).The MIP is a measure of inspiratory muscle strength produced by a sub-atmospheric pressure The normal.range of MIP in elderly people approximately 60 cm H2O for men and 40 cm H2O for women .An absolute MIP value of < - 40 cm H2O is always abnormal,and higher scores was mean a better outcome.
|
assessed at discharge6 weeks.
|
Discharge 6weeks Expiratory Muscle Strength (MEP, cmH2O)
Time Frame: assessed at discharge 6 weeks
|
The Maximal Expiratory Pressure (MEP,cmH2O) are global measures of the maximal strength of the respiratory muscles.(MEP,
cmH2O) .MEP is a supra-atmospheric pressure which can be developed in an effort of the abdominal and intercostal muscles.Expiratory muscle strength assesses extrathoracic muscle health.An absolute MEP value of < 80 cm H2O is always abnormal, and higher scores mean a better outcome.
|
assessed at discharge 6 weeks
|
Discharge 6 Weeks Modified Borg Score
Time Frame: assessed at discharge 6week
|
Dyspnea score as assessed by Modified Borg score, The literature review clearly showed that the Modified Borg score was a valid and reliable tool when used in pulmonary medicine and in exercise physiology studies.The scale used was perceived exertion adapted to be appropriate for measuring dyspnea.
This consisted of a vertical scale labelled 0-10, with corresponding verbal expressions of progressively increasing perceived sensation intensity.
It starts at number 0 that mean breathing is no difficulty at all and progresses through to number 10 that mean breathing difficulty is maximal.so
higher scores mean a worse outcome
|
assessed at discharge 6week
|
Discharge 6weeks Lung Expansion Capacity
Time Frame: assessed at discharge 6 weeks
|
Lung expansion capacity as assessed by incentive spirometry with the flow-oriented device( Triflow II,volume × seconds) (ml)).Incentive spirometry that feedback respiratory training can improve respiratory function, endurance for exercise capacity,Wide flow rate range from 600 - 1200(volume × seconds) (mL)c.higher
scores mean a better outcome.
|
assessed at discharge 6 weeks
|
Postoperative 6weeks Pulmonary Complications
Time Frame: at 6weeks after discharge
|
Pulmonary complication as assessed by Chest X-ray.pneumonia.lung
collapse.atelectasis.emphysema
and pleural effusion were collected.In our research,some patients have two pulmonary complications at the same time, such as emphysem and infiltration, so the total number is not necessarily equal to 18.
|
at 6weeks after discharge
|
Discharge 12 Weeks Forced Vital Capacity (FVC in Liter(L)/Sec )
Time Frame: assessments at discharge 12 weeks
|
Forced vital capacity (FVC in (liter(L)/sec)) assessment by pulmonary function test.Normal values in healthy males aged 20-60 from 4.5-3.5 (liter(L)/sec),and for females from 3.25-2.5
(liter(L)/sec) ,and whether higher scores mean a better outcome.
|
assessments at discharge 12 weeks
|
Discharge 12 Weeks Forced Expiratory Volume in 1 Second(FEV1,Liter(L)/Sec)
Time Frame: assessed at discharge12weeks
|
The Forced Expiratory Volume in 1 Second parameter(FEV1,liter(L)/sec) measures the volume of air that was exhaled into the mouthpiece in the first second after a full inhalation.
The Measured column represents the total volume exhaled during the first second, in liters.
Normal values in healthy males aged 20-60 range from 4.5 to 3.5 liters, and normal values for females aged 20-60 range from 3.25 to 2.5 liters.
The Predicted column compares the actual volume breathed out during the first second of your test to an average of the normal volume breathed out in 1 second for a person of the same gender, height, and age.
This value is expressed as a percentage, with normal test values being between 80% and 120% of the average (predicted) values.and
whether higher scores mean a better outcome.
|
assessed at discharge12weeks
|
Discharge 12 Weeks MMEF 25-75%(Liter(L)/Sec)
Time Frame: assessed at discharge12weeks "
|
Forced expiratory flow (FEF) is the flow (or speed) of air coming out of the lung during the middle portion of a forced expiration.
It can be given at discrete times, generally defined by what fraction of the forced vital capacity (FVC) has been exhaled.
The usual discrete intervals are 25%, 50% and 75%, usually 25-75% (FEF25-75%).Predicted normal values for FEF depend on age, sex, height, mass and ethnicity as well as the research study that they are based on assessment by pulmonary function test and higher scores mean a better outcome.
|
assessed at discharge12weeks "
|
Discharge 12 Weeks Peak Expiratory Flow Rate (PEFR in Liter(L)/Sec)
Time Frame: assessed at discharge 12 weeks
|
Peak expiratory flow rate (PEFR in liter(L)/sec) assessment by pulmonary function test.It measures the airflow through the bronchi and thus the degree of obstruction in the airways.
Peak expiratory flow is typically measured in units of liters per second (L/sec).when
measured as part of spirometry.The normal range 500-700 L/sec In men, for women, the normal range is 380-500 L/sec.higher
scores mean a better outcome.
|
assessed at discharge 12 weeks
|
Discharge 12 Weeks Inspiratory Muscle Strength (MIP,cmH2O)
Time Frame: assessed at discharge12 weeks.
|
Inspiratory muscle strength as assessed by Maximum inspiratory pressure (MIP, cmH2O).The MIP is a measure of inspiratory muscle strength produced by a sub-atmospheric pressure The normal.range of MIP in elderly people approximately 60 cm H2O for men and 40 cm H2O for women .An absolute MIP value of < - 40 cm H2O is always abnormal,and higher scores was mean a better outcome.
|
assessed at discharge12 weeks.
|
Discharge 12weeks Expiratory Muscle Strength(MEP,cmH2O)
Time Frame: assessed at discharge 12weeks
|
The Maximal Expiratory Pressure (MEP,cmH2O) are global measures of the maximal strength of the respiratory muscles.(MEP,
cmH2O) .MEP is a supra-atmospheric pressure which can be developed in an effort of the abdominal and intercostal muscles.Expiratory muscle strength assesses extrathoracic muscle health.An absolute MEP value of < 80 cm H2O is always abnormal, and higher scores mean a better outcome.
|
assessed at discharge 12weeks
|
Discharge 12 Weeks Modified Borg Score
Time Frame: assessed at discharge12weeks
|
Dyspnea score as assessed by Modified Borg score, The literature review clearly showed that the Modified Borg score was a valid and reliable tool when used in pulmonary medicine and in exercise physiology studies.The scale used was perceived exertion adapted to be appropriate for measuring dyspnea.
This consisted of a vertical scale labelled 0-10, with corresponding verbal expressions of progressively increasing perceived sensation intensity.
It starts at number 0 that mean breathing is no difficulty at all and progresses through to number 10 that mean breathing difficulty is maximal.so
higher scores mean a worse outcome
|
assessed at discharge12weeks
|
Discharge 12 Weeks Lung Expansion Capacity
Time Frame: assessed at discharge 12weeks
|
Lung expansion capacity as assessed by incentive spirometry with the flow-oriented device( Triflow II,volume × seconds) (ml)).Incentive spirometry that feedback respiratory training can improve respiratory function, endurance for exercise capacity,Wide flow rate range from 600 - 1200(volume × seconds) (mL)c.higher
scores mean a better outcome.
|
assessed at discharge 12weeks
|
Postoperative 12 Weeks Pulmonary Complications
Time Frame: at 12 weeks after discharge
|
Pulmonary complication as assessed by Chest X-ray.pneumonia.lung
collapse.atelectasis.emphysema
and pleural effusion were collected.some
patients have two pulmonary complications at the same time, such as emphysem and infiltration, so the total number is not necessarily equal to 18.
|
at 12 weeks after discharge
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Jui Fang Liu, PhD, Department of Respiratory Therapy
- Study Chair: Nai Ying Kuo, master, Department of Respiratory Therapy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1046659A3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- CSR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Neoplasms
-
UNC Lineberger Comprehensive Cancer CenterSivan Innovation Ltd.CompletedLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of LungUnited States
-
Baptist Health South FloridaWithdrawnLung Cancer | Lung TumorUnited States
-
Oliver JonasMassachusetts General HospitalCompletedLung Cancer | Lung TumorUnited States
-
C. R. BardCompleted
-
Portsmouth Hospitals NHS TrustCompletedLung Cancer | Interstitial Lung DiseaseUnited Kingdom
-
Azienda Sanitaria-Universitaria Integrata di UdineRecruitingLung Diseases | Lung Cancer | Lung Adenocarcinoma | Lung Transplant Rejection | Lung; Node | Lung TBItaly
-
Point TherapeuticsTerminatedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, PulmonaryUnited States
-
University of UtahRecruitingLung Cancer | Lung Neoplasms/DiagnosisUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Carcinoma | Lung Neoplasm | Malignant Lung NeoplasmUnited States
-
Keimyung University Dongsan Medical CenterCompletedLung Cancer | Lung Diseases, Interstitial
Clinical Trials on Home-based Pulmonary Rehabilitation
-
Istanbul Medipol University HospitalRecruitingLung Diseases | Bronchiectasis | Lung Diseases, Interstitial | Pulmonary RehabilitationTurkey
-
Istanbul Medipol University HospitalCompletedEmphysema | Bronchoscopic Lung Volume Reduction | Hospital-based Pulmonary Rehabilitation | Home-based Pulmonary RehabilitationTurkey
-
La Trobe UniversityMonash University; The Alfred; Austin HealthCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
Mayo ClinicBoehringer IngelheimRecruitingFibrotic Interstitial Lung DiseaseUnited States
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Monash UniversityUniversity of Melbourne; La Trobe University; Institute for Breathing and Sleep... and other collaboratorsRecruitingChronic Obstructive Pulmonary DiseaseAustralia
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedCOPD ExacerbationUnited States
-
Centre de Recherche de l'Institut Universitaire...Completed
-
Copenhagen University Hospital, HvidovreCopenhagen University Hospital Bispebjerg-Frederiksberg; Copenhagen University... and other collaboratorsRecruiting